Haemolytic-uraemic	haemolytic-uraemic	O	O
syndrome	syndrome	O	S_disease
after	after	O	O
treatment	treatment	O	O
with	with	O	O
metronidazole	metronidazole	S_chemicals	O
.	.	O	O

This	this	O	O
paper	paper	O	O
describes	describes	O	O
the	the	O	O
clinical	clinical	O	O
features	features	O	O
of	of	O	O
six	six	O	O
children	children	O	O
who	who	O	O
developed	developed	O	O
the	the	O	O
haemolytic-uraemic	haemolytic-uraemic	O	O
syndrome	syndrome	O	S_disease
after	after	O	O
treatment	treatment	O	O
with	with	O	O
metronidazole	metronidazole	S_chemicals	O
.	.	O	O

These	these	O	O
children	children	O	O
were	were	O	O
older	older	O	O
and	and	O	O
were	were	O	O
more	more	O	O
likely	likely	O	O
to	to	O	O
have	have	O	O
undergone	undergone	O	O
recent	recent	O	O
bowel	bowel	O	O
surgery	surgery	O	O
than	than	O	O
are	are	O	O
other	other	O	O
children	children	O	O
with	with	O	O
this	this	O	O
condition	condition	O	O
.	.	O	O

While	while	O	O
the	the	O	O
involvement	involvement	O	O
of	of	O	O
metronidazole	metronidazole	S_chemicals	O
in	in	O	O
the	the	O	O
aetiology	aetiology	O	O
of	of	O	O
the	the	O	O
haemolytic-uraemic	haemolytic-uraemic	O	O
syndrome	syndrome	O	S_disease
is	is	O	O
not	not	O	O
established	established	O	O
firmly	firmly	O	O
,	,	O	O
the	the	O	O
action	action	O	O
of	of	O	O
this	this	O	O
drug	drug	S_chemicals	O
in	in	O	O
sensitizing	sensitizing	O	O
tissues	tissues	O	O
to	to	O	O
oxidation	oxidation	O	O
injury	injury	O	S_disease
and	and	O	O
the	the	O	O
reported	reported	O	O
evidence	evidence	O	O
of	of	O	O
oxidation	oxidation	O	O
changes	changes	O	O
in	in	O	O
the	the	O	O
haemolytic-uraemic	haemolytic-uraemic	O	O
syndrome	syndrome	O	S_disease
suggest	suggest	O	O
a	a	O	O
possible	possible	O	O
link	link	O	O
between	between	O	O
metronidazole	metronidazole	S_chemicals	O
treatment	treatment	O	O
and	and	O	O
some	some	O	O
cases	cases	O	O
of	of	O	O
the	the	O	O
haemolytic-uraemic	haemolytic-uraemic	O	O
syndrome	syndrome	O	S_disease
.	.	O	O

